RSI spoločnosti QSAM Biosciences
Aká je hodnota metriky RSI spoločnosti QSAM Biosciences?
Hodnota metriky RSI spoločnosti QSAM Biosciences, Inc. je 68.60
Aká je definícia metriky RSI?
Index relatívnej sily (Relative strength index - RSI 14) je technický ukazovateľ, ktorý sa radí medzi momentum indikátory a meria rýchlosť a zmenu ceny. Jeho hodnota sa pohybuje medzi 0 a 100 a používa sa na charakterizovanie prekupovaného a prepredaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou QSAM Biosciences
Čomu sa venuje spoločnosť QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Firmy s metrikou rsi podobnou spoločnosti QSAM Biosciences
- Hodnota metriky RSI spoločnosti Real Estate & E-Comm Split je 68.58
- Hodnota metriky RSI spoločnosti Templeton Global Growth Fund je 68.58
- Hodnota metriky RSI spoločnosti Dolly Varden Silver je 68.58
- Hodnota metriky RSI spoločnosti Majestic Gold je 68.58
- Hodnota metriky RSI spoločnosti TCW Strategic Income Fund Inc je 68.59
- Hodnota metriky RSI spoločnosti LHN je 68.59
- Hodnota metriky RSI spoločnosti QSAM Biosciences je 68.60
- Hodnota metriky RSI spoločnosti SK Telecom Co Ltd je 68.61
- Hodnota metriky RSI spoločnosti GFL je 68.61
- Hodnota metriky RSI spoločnosti EPR Properties je 68.61
- Hodnota metriky RSI spoločnosti Alembic Pharmaceuticals je 68.61
- Hodnota metriky RSI spoločnosti Marico je 68.62
- Hodnota metriky RSI spoločnosti Calnex Solutions Plc je 68.63